Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lees

Showing results (301-310 of 804) with videos related to

Pageof 81
Sort By:
Journal of Veterinary Pharmacology and Therapeutics|March 18, 2014
Differential pharmacokinetics and pharmacokinetic/pharmacodynamic modelling of robenacoxib and ketoprofen in a feline model of inflammationL Pelligand, J N King, V Hormazabal, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 11, 2012
Structure-guided topographic mapping and mutagenesis to elucidate binding sites for the human ether-a-go-go-related gene 1 potassium channel (KCNH2) activator NS1643Serdar Durdagi, Jiqing Guo, James P Lees-Miller, et al.
The Veterinary Record|August 13, 2017
Comparison of veterinary drugs and veterinary homeopathy: part 1P Lees, L Pelligand, M Whiting, et al.
Equine Veterinary Journal|November 5, 1997
Influence of antigen challenge on platelet responsiveness in horses with chronic obstructive pulmonary diseaseJ M Ablett, S M Fairbairn, C P Page, et al.
Journal of Veterinary Pharmacology and Therapeutics|January 24, 2009
Use of a pharmacokinetic/pharmacodynamic approach in the cat to determine a dosage regimen for the COX-2 selective drug robenacoxibJ M Giraudel, J N King, E C Jeunesse, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|February 28, 2013
XRCC4 and XLF form long helical protein filaments suitable for DNA end protection and alignment to facilitate DNA double strand break repairBrandi L Mahaney, Michal Hammel, Katheryn Meek, et al.
The Cornell Veterinarian|April 1, 1987
Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horseP Lees, J B Taylor, T E Maitho, et al.
The Veterinary Record|August 20, 2017
Comparison of veterinary drugs and veterinary homeopathy: part 2P Lees, L Pelligand, M Whiting, et al.
The Analyst|February 4, 2017
Nanospray HX-MS configuration for structural interrogation of large protein systemsJoey G Sheff, Morgan Hepburn, Yaping Yu, et al.
Research in Veterinary Science|September 1, 1996
Effects of platelet activating factor on the distribution of radiolabelled leucocytes and platelets in normal horses and asymptomatic horses with chronic obstructive pulmonary diseaseS M Fairbairn, K A Marr, P Lees, et al.
Pageof 81

Showing results (301-310 of 804) with videos related to

Sort By:
Pageof 81
Journal of Veterinary Pharmacology and Therapeutics|March 18, 2014
Differential pharmacokinetics and pharmacokinetic/pharmacodynamic modelling of robenacoxib and ketoprofen in a feline model of inflammationL Pelligand, J N King, V Hormazabal, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 11, 2012
Structure-guided topographic mapping and mutagenesis to elucidate binding sites for the human ether-a-go-go-related gene 1 potassium channel (KCNH2) activator NS1643Serdar Durdagi, Jiqing Guo, James P Lees-Miller, et al.
The Veterinary Record|August 13, 2017
Comparison of veterinary drugs and veterinary homeopathy: part 1P Lees, L Pelligand, M Whiting, et al.
Equine Veterinary Journal|November 5, 1997
Influence of antigen challenge on platelet responsiveness in horses with chronic obstructive pulmonary diseaseJ M Ablett, S M Fairbairn, C P Page, et al.
Journal of Veterinary Pharmacology and Therapeutics|January 24, 2009
Use of a pharmacokinetic/pharmacodynamic approach in the cat to determine a dosage regimen for the COX-2 selective drug robenacoxibJ M Giraudel, J N King, E C Jeunesse, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|February 28, 2013
XRCC4 and XLF form long helical protein filaments suitable for DNA end protection and alignment to facilitate DNA double strand break repairBrandi L Mahaney, Michal Hammel, Katheryn Meek, et al.
The Cornell Veterinarian|April 1, 1987
Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horseP Lees, J B Taylor, T E Maitho, et al.
The Veterinary Record|August 20, 2017
Comparison of veterinary drugs and veterinary homeopathy: part 2P Lees, L Pelligand, M Whiting, et al.
The Analyst|February 4, 2017
Nanospray HX-MS configuration for structural interrogation of large protein systemsJoey G Sheff, Morgan Hepburn, Yaping Yu, et al.
Research in Veterinary Science|September 1, 1996
Effects of platelet activating factor on the distribution of radiolabelled leucocytes and platelets in normal horses and asymptomatic horses with chronic obstructive pulmonary diseaseS M Fairbairn, K A Marr, P Lees, et al.
Pageof 81